Inventor

STROBEL HARTMUT

DE51 patents

⚠️ This page may combine multiple inventors who share the name “STROBEL HARTMUT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STROBEL HARTMUT

AVENTIS PHARMA GMBH

Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same

Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents

Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceutical preparations containing same

Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators

4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical

Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents

Substituted isoindolones and their use as cyclic GMP modulators in medicaments

Luminescent method of detecting soluble guanylate cyclase

Method for detecting oxidized forms of soluble guanylate cyclase

Substituted 4-amino-2-aryl-tetrahydoquinazolines, their preparation, their use and pharmaceutical preparations comprising them

Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators

SANOFI AVENTIS DEUTSCHLAND

Acylated arylcycloalkylamines and their use as pharmaceuticals

Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals

Acylated indanyl amines and their use as pharmaceuticals

Method for screening for activators of soluble guanylate cyclase having oxidized heme iron

4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical

Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them

Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators

Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them

Acylated indanyl amines and their use as pharmaceuticals

Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals

SANOFI SA

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Biaryl-propionic acid derivatives and their use as pharmaceuticals

Biaryl-propionic acid derivatives and their use as pharmaceuticals

Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase

STROBEL HARTMUT

Heteroarylacrylamides and their use as pharmaceuticals

Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals

Heteroaryl-substituted carboxamides and their use as pharmaceuticals

Acylated indanyl amines and their use as pharmaceuticals

AVENTIS PHARMA SA

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

ZOLLER GERHARD

Imidazo[1,2-a]pyridines and their use as pharmaceuticals

Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals

Imidazo[2,1-b]thiazoles and their use as pharmaceuticals

SCHINDLER URSULA

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

SANOFI AVERTIS DEUTSCHLAND GMB

Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals

SANOFI AVENTIS

Imidazo[1,2-a]azines and their use as pharmaceuticals

KROG ALEXANDRA

Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1